MylanItem # 716302MPN 67457016302

Sotradecol 3% 30 mg/mL 2 mL Vial, 5/Bx

In StockPrescription required

This item is prescription-controlled. A valid medical license must be on file for your account before it can be ordered.

SOTRADECOL®* 3% (Sodium Tetradecyl Sulfate Injection)

Sotradecol (sodium tetradecyl sulfate injection) is a sclerosing agent. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.

NDC 67457-163-02

60 mg/2 mL (30 mg/mL)

5 x 2 mL Multiple-Dose Vials

Store at 20° to 25°C (68° to 77°F).

Manufacturer: Mylan
Sold By: Box of 5

How does Sotradecol 3% work to treat varicose veins compared to other treatments available?

Sotradecol 3% works by causing inflammation and thrombus formation in the vein's intima after intravenous injection, leading to vein occlusion and potentially permanent obliteration, a mechanism different from non-sclerosing treatments like laser or surgery. [Manufacturer Info]

What are the potential side effects I should prepare my patients for when administering Sotradecol?

Common side effects of Sotradecol may include localized pain, inflammation at the injection site, and thrombus formation, which are typical reactions due to its sclerosing action. [Manufacturer Info]

As a clinician, what are the key indicators that Sotradecol is effectively occluding the targeted area?

Effective occlusion with Sotradecol is typically indicated by visual and ultrasound confirmation of reduced blood flow and vein closure post-treatment. [Manufacturer Info]

Can Sotradecol be combined with other treatments, or should it be used in isolation?

Sotradecol can be used in combination with other vein treatment modalities depending on individual patient needs and treatment plans, but consultation with a specialist is recommended. [Manufacturer Info]

How should I instruct my patients to prepare for their procedure using Sotradecol?

Patients should be advised to avoid anti-inflammatory drugs before the procedure, remain hydrated, and wear loose clothing on the day of their Sotradecol injection. [Manufacturer Info]

Sotradecol 3% 30 mg/mL 2 mL Vial, 5/Bx

Sotradecol 3% 30 mg/mL 2 mL Vial, 5/Bx

Sotradecol 3% 30 mg/mL 2 mL Vial, 5/Bx

Frequently bought together

Bupivacaine 0.5% 150 mg/30 mL 5 mg/mL 30 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Bupivacaine 0.25% 75 mg/30 mL 2.5 mg/mL 30 mL SDV, 25/Bx

Sotradecol 3% 30 mg/mL 2 mL Vial, 5/Bx

Frequently bought together

Bupivacaine 0.5% 150 mg/30 mL 5 mg/mL 30 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Bupivacaine 0.25% 75 mg/30 mL 2.5 mg/mL 30 mL SDV, 25/Bx

Frequently bought together

Bupivacaine 0.5% 150 mg/30 mL 5 mg/mL 30 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Bupivacaine 0.25% 75 mg/30 mL 2.5 mg/mL 30 mL SDV, 25/Bx

Frequently bought together

Bupivacaine 0.5% 150 mg/30 mL 5 mg/mL 30 mL SDV, 25/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Bupivacaine 0.25% 75 mg/30 mL 2.5 mg/mL 30 mL SDV, 25/Bx